Free shipping on all orders over $ 500

MKC-3946

Cat. No. M10395

All AbMole products are for research use only, cannot be used for human consumption.

MKC-3946 Structure
Synonym:

MKC3946

Size Price Availability Quantity
1mg USD 70 In stock
5mg USD 200 In stock
10mg USD 320 In stock
25mg USD 680 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

MKC-3946 is a potent IRE1α inhibitor which triggered modest growth inhibition in multiple myeloma cell lines. MKC-3946 blocks XBP1 mRNA splicing and exhibit cytotoxicity against AML cells. MKC-3946 inhibits XBP1S expression induced by tunicamycin (TM) in NB4 cells (B) and AML. MKC-3946 prevents the splicing of the XBP1 mRNA in response to ER stress caused by mutant proinsulin production. MKC-3946 (10μM) enhances ER stress-mediated apoptosis induced by bortezomib or 17-AAG, and enhances cytotoxicity of ER stressors, even in the presence of BMSCs or exogenous IL-6.

In vivo, MKC-3946 (100 mg/kg, i.p.) inhibits XBP1 splicing in a model of ER stress in vivo, associated with significant growth inhibition of MM cells, alone or with bortezomib. MKC-3946 significantly reduces MM tumor growth in the treatment versus control group.

Chemical Information
Molecular Weight 380.46
Formula C21H20N2O3S
CAS Number 1093119-54-0
Solubility (25°C) DMSO 20 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Aurelia Lugea, et al. Gastroenterology. The Combination of Alcohol and Cigarette Smoke Induces Endoplasmic Reticulum Stress and Cell Death in Pancreatic Acinar Cells

[2] Haibo Sun, et al. Oncotarget. Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia

[3] Liling Zhang, et al. BMC Cell Biol. IRE1 inhibition perturbs the unfolded protein response in a pancreatic β-cell line expressing mutant proinsulin, but does not sensitize the cells to apoptosis

[4] Naoya Mimura, et al. Blood. Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma

Related IRE1 Products
4μ8C

4μ8C is a potent and selective IRE1 Rnase inhibitor with IC50 of 76 nM.

STF-083010

STF-083010 is a potent inhibitor of the ER transmembrane protein IRE1, which mediates the unfolded protein response.

KIRA6

KIRA6 is a potent type II IRE1α kinase inhibitor with an IC50 of 0.6 µM.

Kira8

Kira8 (AMG-18) is a single selective IRE1α inhibitor with an IC50 of 5.9 nM.

GSK2850163

GSK2850163 is a novel inhibitor of inositol-requiring enzyme-1 alpha (IRE1α) which can inhibit IRE1α kinase activity and RNase activity with IC50s of 20 and 200 nM, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: MKC-3946, MKC3946 supplier, IRE1, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.